Form 4: Entegris SVP Exercises, Sells Options; Receives RSU Grant
Insider Transaction Report
Entegris SVP Daniel D. Woodland exercised and immediately sold a total of 30,474 stock options, realizing significant gains, while also receiving a grant of 10,694 restricted stock units.
Summary
- Daniel D. Woodland, SVP & President, MS Division of Entegris Inc. (ENTG), reported multiple transactions on February 12, 2026.
- Received a grant of 10,694 restricted stock units (RSUs) at a price of $0.00, which will vest 50% on February 19, 2027, and 50% on February 19, 2028.
- Exercised 5,151 employee stock options at an exercise price of $55.88 and simultaneously sold the acquired common stock at $130.80 per share.
- Exercised 12,656 employee stock options at an exercise price of $70.03 and simultaneously sold the acquired common stock at a weighted average price of $130.71 per share (ranging from $130.70 to $130.87).
- Exercised 12,667 employee stock options at an exercise price of $79.97 and simultaneously sold the acquired common stock at a weighted average price of $130.52 per share (ranging from $130.46 to $130.66).
- All exercised options were fully vested.
- The transactions were conducted under a Rule 10b5-1 pre-arranged trading plan.
- Following these transactions, Woodland's direct beneficial ownership of common stock remains at 46,903.83 shares, which includes the recently awarded RSUs and 121.09 shares from the Employee Stock Purchase Plan.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While an executive selling shares might typically be seen as negative, the context of a 10b5-1 plan and the simultaneous grant of new restricted stock units mitigates concerns, suggesting routine compensation management rather than a lack of confidence.
Positives
- Daniel D. Woodland received a grant of 10,694 restricted stock units, aligning his interests with long-term company performance.
- Woodland realized significant gains by exercising stock options at lower prices ($55.88, $70.03, $79.97) and selling the shares at substantially higher market prices ($130.80, $130.71, $130.52).
- The transactions were executed under a Rule 10b5-1 plan, indicating pre-planned sales and reducing concerns about opportunistic insider trading.
Negatives
- The immediate sale of all shares acquired through option exercises represents a reduction in direct equity exposure to the company's unrestricted common stock by the SVP.
- A total of 30,474 shares were sold by a key executive, which could be interpreted as a lack of conviction in the near-term stock price, although mitigated by the 10b5-1 plan.
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing.
Industry Context
StockSavvy.ai notes that executive stock option exercises and sales are common events in the technology and materials industry, particularly for mature companies like Entegris. These transactions often reflect executives managing their personal portfolios, diversifying holdings, or realizing compensation, especially when executed under pre-arranged 10b5-1 plans.
Comparison to Industry Standards
- Executive compensation structures, including stock options and restricted stock units, are standard practice across the semiconductor materials and advanced manufacturing industries.
- The exercise and sale of options at a profit, followed by a grant of RSUs, is a typical pattern for retaining and incentivizing senior leadership.
- Similar compensation and trading patterns are observed at companies like Applied Materials (AMAT) or KLA Corporation (KLAC), where executives frequently use 10b5-1 plans to manage their equity holdings.
- The profit margins on these option exercises (e.g., buying at $55.88 and selling at $130.80) are indicative of significant stock price appreciation over the vesting period, which is a positive sign for long-term shareholders.
Related Party Transactions
- The transactions involve an executive and the company's securities, which are inherently related-party dealings in the context of insider reporting.
Stakeholder Impact
- Shareholders: The sale of shares by an executive could be perceived negatively, but the 10b5-1 plan and the RSU grant suggest routine compensation management. The executive's continued beneficial ownership, including future vesting RSUs, maintains alignment with shareholder interests.
- Employees: The filing details executive compensation practices, which can influence broader employee compensation strategies and morale.
Next Steps
- 50% of the 10,694 restricted stock units will vest on February 19, 2027.
- The remaining 50% of the 10,694 restricted stock units will vest on February 19, 2028.
Key Dates
| Date | Description |
|---|---|
| 12/31/2025 | 121.09 shares acquired under the Entegris, Inc. Employee Stock Purchase Plan. |
| 02/12/2026 | Date of earliest transaction, including RSU award, option exercises, and stock sales. |
| 02/17/2026 | Date the Form 4 was signed. |
| 02/19/2027 | 50% of the 10,694 restricted stock units lapse restrictions. |
| 02/19/2028 | Remaining 50% of the 10,694 restricted stock units lapse restrictions. |
| 12/06/2028 | Expiration date for 5,151 employee stock options (already exercised). |
| 12/05/2029 | Expiration date for 12,656 employee stock options (already exercised). |
| 12/03/2030 | Expiration date for 12,667 employee stock options (already exercised). |
Recommendation
holdThe filing details routine insider transactions (option exercises and sales under a 10b5-1 plan, plus an RSU grant) by a senior executive. These actions are typical for executive compensation and personal financial management and do not provide new material information about the company's operational performance or strategic direction that would warrant a change in investment recommendation. The executive maintains significant equity exposure through remaining shares and future RSU vesting.
Keywords
Entegris, ENTG, Daniel D. Woodland, insider trading, Form 4, stock options, restricted stock units, RSU, stock sale, executive compensation, 10b5-1 plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.